Background paper to the recommendation for the preferential use of live-attenuated influenza vaccine in children aged 2–6 years in Germany

Date:  24/10/2013

Bundesgesundheitsbl 2013 · 56:1557-1564
DOI 10.1007/s00103-013-1844-9
© Springer-Verlag Berlin Heidelberg 2013